#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arterial disorder Neuroendocrine tumour of the lung Astrocytoma Necrotising enterocolitis neonatal Marfan's syndrome Vascular malformation Human papilloma virus immunisation Duchenne muscular dystrophy Hypersensitivity pneumonitis Giant cell tumour of tendon sheath Angiosarcoma Liver transplant rejection Burkitt's lymphoma Neuroendocrine carcinoma Enteritis More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Basic Information Usher’s syndrome – Life with Disease Retinoblastoma – Trials in Disease Myelodysplastic syndrome – Trials in Disease Short-bowel syndrome – Basic Information Lymphangioma – Diagnostics Arterial tortuosity syndrome – Diagnostics Retinitis pigmentosa Myelodysplastic syndrome with excess blasts – Life with Disease Gastrointestinal stromal tumour – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Warfarin Sodium Aficamten Tovorafenib Peboctocogene Camaparvovec Betamethasone Dipropionate Specific Nucleic Acid Sna-Xfsc Amb-05X Thymalfasin Enfortumab Vedotin Carfilzomib Holcus Lanatus Pollen Extract Phosphocreatine Sodium Repagermanium Midostaurin Rmc-035 Riluzole Crinecerfont RLY-2608 Dexamethasone Acetate Ph. Eur. ATIRMOCICLIB More therapies…

    Learn about Your Condition

    Migraine without aura Narcolepsy Asthmatic crisis Androgenetic alopecia Hypertrophic scar Head and neck cancer Netherton's syndrome Mantle cell lymphoma stage IV Type 2 diabetes mellitus Pemphigus Skin disorder Proteinuria Vaginal cancer Yellow fever Thymic carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Dinutuximab Beta
    • Topotecan
    • Bevacizumab
    Austria Belgium Denmark France Germany Italy +4

  • Study on BCG Vaccine and Rabies Virus (Inactivated) for Healthy Volunteers: Exploring Pre-Vaccination Immune Status and Its Impact on Vaccine Response

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mycobacterium Bovis, Danish Strain 1331
    The Netherlands

  • Vusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Vusolimogene Oderparepvec
    • Relatlimab
    • Dacarbazine Citrate
    France Germany Greece Italy Poland Spain

  • Effectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis

    Recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Abrocitinib
    Germany Hungary Poland Spain

  • Study of Continuous Infusion of Cloxacillin Using Elastomeric Pump in Adult Patients with Staphylococcus Aureus Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Cloxacillin Sodium
    Sweden

  • Study Evaluating Direct Oral Anticoagulants for Prevention of Blood Clots in Patients with Hypertrophic Cardiomyopathy and Abnormal Left Atrial Function

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Rivaroxaban
    France
Previous Page
1 … 174 175 176 177 178 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!